No Data
No Data
Satsuma Pharmaceuticals and SNBL Announce Publication of STS101 (Dihydroergotamine Nasal Powder) Pivotal Phase 3 ASCEND Study in CNS Drugs
Shin Nippon Biomedical Laboratories To Go Ex-Dividend On September 27th, 2024 With 20 JPY Dividend Per Share
September 26th (Japan Standard Time) - $Shin Nippon Biomedical Laboratories(2395.JP)$ is trading ex-dividend on September 27th, 2024.Shareholders of record on September 30th, 2024 will receive 20
Shin Nippon Biomedical, SBI to Launch $40 Million Fund for North American Startups
List of Cloud Breakout Stocks [Ichimoku Balance Table, List of Cloud Breakout Stocks]
List of cloud-based stocks on the market Code Stock Name Closing Price Leading Span A Leading Span B Tokyo Stock Exchange Prime <1766> Takeda Construction 11740 11055 11425 <5032> ANYCOLOR 2531 2293.25 2414.5 <5471> Daito Special Steel 1374 1313 1367.5 <6184> Kamakura Shinsho
Shin Nippon Biomedical Laboratories Changes Name of Subsidiary Ina Research to SNBL Ina
SNBL Partners With Astellas Pharma in Drug Discovery
No Data
No Data